+44 (0)1865 572846
Fax +44 (0)1865 740449
Cardiovascular DIsease and Pregnancy Research Collaborative
Cardiovascular Clinical Research Facility
- Paul Leeson
DPHIL OPPORTUNITIES AVAILABLE
PhD FRCP FESC
Professor of Cardiovascular Medicine
- Head of Oxford Cardiovascular Clinical Research Facility
- Consultant Physician
Cardiovascular Imaging and Early Development of Cardiovascular Disease
Paul Leeson is Professor of Cardiovascular Medicine at the University of Oxford, Fellow at Wolfson College and Head of the Oxford Cardiovascular Clinical Research Facility. He is also a Consultant Cardiologist at the John Radcliffe Hospital, where he provides expertise in Cardiovascular Imaging, as well as General Cardiology and Cardiovascular Prevention through the Oxford Specialist Hypertension Clinic.
He heads the Preventive Cardiology Research Group, based in the Oxford Cardiovascular Clinical Research Facility, which aims to improve how we identify and prevent heart disease in young people. The group works in three areas:
- Novel markers of early disease - Using imaging and laboratory studies to identify early cardiac and vascular changes in young people at risk of cardiovascular disease. In particular, those predisposed to hypertension, such as families with a history of preeclampsia or preterm birth.
- Young adult cardiovascular prevention trials - Running trials to understand how novel approaches to lifestyle and clinical management can modify early risk cardiovascular phenotypes to prevent the development of later disease.
- Artificial intelligence - Pioneering use of artificial intelligence to improve the clinical tools already available to identify those at risk, such as echocardiography, and identify next generation imaging and management approaches.
He sits on the NIHR i4i and Fellowship funding panels, NICE Cardiovascular Disease Prevention Guideline committee and UK Biobank Imaging Advisory Board. In addition, he is a National Cardiology Lead for the NIHR Clinical Research Network and member of research collaborative working groups within the European Association of Preventive Cardiology, British Cardiovascular Society and British and Irish Hypertension Society.